Correlation Between Procept Biorobotics and Neuropace

Can any of the company-specific risk be diversified away by investing in both Procept Biorobotics and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Procept Biorobotics and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Procept Biorobotics Corp and Neuropace, you can compare the effects of market volatilities on Procept Biorobotics and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Procept Biorobotics with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Procept Biorobotics and Neuropace.

Diversification Opportunities for Procept Biorobotics and Neuropace

0.06

Correlation Coefficient

Procept Biorobotics  Neuropace

Significant diversification

The 3 months correlation between Procept and Neuropace is 0.06. Overlapping area represents the amount of risk that can be diversified away by holding Procept Biorobotics Corp and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Procept Biorobotics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Procept Biorobotics Corp are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Procept Biorobotics i.e., Procept Biorobotics and Neuropace go up and down completely randomly.

Pair Corralation between Procept Biorobotics and Neuropace

Given the investment horizon of 90 days Procept Biorobotics Corp is expected to under-perform the Neuropace. But the stock apears to be less risky and, when comparing its historical volatility, Procept Biorobotics Corp is 1.16 times less risky than Neuropace. The stock trades about -0.13 of its potential returns per unit of risk. The Neuropace is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,087  in Neuropace on December 30, 2024 and sell it today you would earn a total of  98.00  from holding Neuropace or generate 9.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Procept Biorobotics Corp  vs.  Neuropace

Procept Biorobotics Corp

Risk-Adjusted Performance

Very Weak

Over the last 90 days Procept Biorobotics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's fundamental indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Procept Biorobotics and Neuropace

The main advantage of trading using opposite Procept Biorobotics and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Procept Biorobotics position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Procept Biorobotics Corp and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.